Literature DB >> 23152128

Endoplasmic reticulum stress induces hepatic steatosis via increased expression of the hepatic very low-density lipoprotein receptor.

Hyunsun Jo1, Sung Sik Choe, Kyung Cheul Shin, Hagoon Jang, Jae Ho Lee, Je Kyung Seong, Sung Hoon Back, Jae Bum Kim.   

Abstract

UNLABELLED: Recent evidence suggests that obese animals exhibit increased endoplasmic reticulum (ER) stress in the liver and adipose tissue. Although ER stress is closely associated with lipid homeostasis, it is largely unknown how ER stress contributes to hepatic steatosis. In this study, we demonstrate that the induction of ER stress stimulates hepatic steatosis through increased expression of the hepatic very low-density lipoprotein receptor (VLDLR). Among the unfolded protein response sensors, the protein kinase RNA-like ER kinase-activating transcription factor 4 signaling pathway was required for hepatic VLDLR up-regulation. In primary hepatocytes, ER stress-dependent VLDLR expression induced intracellular triglyceride accumulation in the presence of very low-density lipoprotein. Moreover, ER stress-dependent hepatic steatosis was diminished in the livers of VLDLR-deficient and apolipoprotein E-deficient mice compared with wild-type mice. In addition, the VLDLR-deficient mice exhibited decreased hepatic steatosis upon high-fat diet feeding.
CONCLUSION: These data suggest that ER stress-dependent expression of hepatic VLDLR leads to hepatic steatosis by increasing lipoprotein delivery to the liver, which might be a novel mechanism explaining ER stress-induced hepatic steatosis.
Copyright © 2012 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23152128     DOI: 10.1002/hep.26126

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  81 in total

1.  Nuclear factor (erythroid-derived 2)-like 2 activation-induced hepatic very-low-density lipoprotein receptor overexpression in response to oxidative stress contributes to alcoholic liver disease in mice.

Authors:  Zhigang Wang; Xiaobing Dou; Songtao Li; Ximei Zhang; Xinguo Sun; Zhanxiang Zhou; Zhenyuan Song
Journal:  Hepatology       Date:  2014-02-25       Impact factor: 17.425

2.  Oral administration of a new HRI activator as a new strategy to improve high-fat-diet-induced glucose intolerance, hepatic steatosis, and hypertriglyceridaemia through FGF21.

Authors:  Mohammad Zarei; Eugènia Pujol; Tania Quesada-López; Francesc Villarroya; Emma Barroso; Santiago Vázquez; Javier Pizarro-Delgado; Xavier Palomer; Manuel Vázquez-Carrera
Journal:  Br J Pharmacol       Date:  2019-05-23       Impact factor: 8.739

Review 3.  Liver function and dysfunction - a unique window into the physiological reach of ER stress and the unfolded protein response.

Authors:  D Thomas Rutkowski
Journal:  FEBS J       Date:  2018-02-07       Impact factor: 5.542

4.  Hepatocyte-specific, PPARγ-regulated mechanisms to promote steatosis in adult mice.

Authors:  Abigail Wolf Greenstein; Neena Majumdar; Peng Yang; Papasani V Subbaiah; Rhonda D Kineman; Jose Cordoba-Chacon
Journal:  J Endocrinol       Date:  2016-10-31       Impact factor: 4.286

5.  TM6SF2 rs58542926 variant affects postprandial lipoprotein metabolism and glucose homeostasis in NAFLD.

Authors:  Giovanni Musso; Ugo Cipolla; Maurizio Cassader; Silvia Pinach; Francesca Saba; Franco De Michieli; Elena Paschetta; Daria Bongiovanni; Luciana Framarin; Nicola Leone; Mara Berrutti; Floriano Rosina; Stefania Corvisieri; Federica Molinaro; Antonio Sircana; Roberto Gambino
Journal:  J Lipid Res       Date:  2017-02-27       Impact factor: 5.922

6.  Hepatitis C virus utilizes VLDLR as a novel entry pathway.

Authors:  Saneyuki Ujino; Hironori Nishitsuji; Takayuki Hishiki; Kazuo Sugiyama; Hiroshi Takaku; Kunitada Shimotohno
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-23       Impact factor: 11.205

Review 7.  Role of Nrf2 in chronic liver disease.

Authors:  Wei Tang; Yong-Fang Jiang; Murugavel Ponnusamy; Mamadou Diallo
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 8.  Snapshot: implications for melatonin in endoplasmic reticulum homeostasis.

Authors:  Wei Hu; Zhiqiang Ma; Shouyin Di; Shuai Jiang; Yue Li; Chongxi Fan; Yang Yang; Dongjin Wang
Journal:  Br J Pharmacol       Date:  2016-11-16       Impact factor: 8.739

9.  Inhibition of mitochondrial β-oxidation by miR-107 promotes hepatic lipid accumulation and impairs glucose tolerance in vivo.

Authors:  H Bhatia; B R Pattnaik; M Datta
Journal:  Int J Obes (Lond)       Date:  2015-10-26       Impact factor: 5.095

10.  Activating transcription factor 4 underlies the pathogenesis of arsenic trioxide-mediated impairment of macrophage innate immune functions.

Authors:  Ritesh K Srivastava; Changzhao Li; Yong Wang; Zhiping Weng; Craig A Elmets; Kevin S Harrod; Jessy S Deshane; Mohammad Athar
Journal:  Toxicol Appl Pharmacol       Date:  2016-07-25       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.